BELKYRA® Double Chin Treatment

Double chin is characterized by localized fat accumulation in the submental region, making people feel older and more overweight than they actually are, and brings impact to both men and women.

Double chin maybe due to:

  • Genetics

  • Aging

  • Weight Change

The only FDA approved treatment for undesirable submental fullness 

Belkyra is a new, patented formulation of Deoxycholic Acid (DCA), which is biologically equivalent to naturally occurring molecule. 

 

Targeting submental fullness, Belkyra disrupts adipocyte membranes, leading to irreversible fat cell breakdown. 

  • Permanently destroy fat cells

  • Non-surgical procedure 

  • US FDA and EMA approved 

  • The only FDA approved treatment for undesirable submental fullness 

  • Average 2-4 treatment sessions for permanent fat cell breakdown

  • Research proven - Long-term safety study data up to 5 years 

Related Treatments:

Juvederm MD codes 美感密碼
Juvederm Volite 保濕針
Teosyal Redensity 黑眼圈針
Show More

*療程效果視乎個人體質,因人而異

Make an Appointment

銅鑼灣霎東街11-13號The Sharp 25樓全層

 

25/F The Sharp,

11-13 Sharp Street East, Causeway Bay, Hong Kong

 

銅鑼灣港鐵站A出口(時代廣場後面)

Causeway Bay MTR Exit A

 

敬請預約 ( by appointment only)

星期一至五 Mon-Fri:                      10am-8pm

星期六 Sat:                                      9:30am-6:30pm

星期日及公眾假期

Sun & public holiday:                    休息 Off​

 

Tel:                              2522 2205

WhatsApp/WeChat:  9844 2963

 

Email: medicglow@gmail.com

Find us
聯絡我們 Contact us

Copyright 2020 Maxicare Limited / Medic Glow all rights reserved.